|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||13.86 - 14.41|
|52 Week Range||8.31 - 27.84|
|PE Ratio (TTM)||-4.35|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|
Valeant Pharmaceuticals is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.
Valeant Pharmaceuticals International Inc NYSE:VRX
Short seller GlassHouse Research has accused medical device company NuVasive, Inc. (NASDAQ: NUVA ) of “irregular accounting” practices and says the stock has more than 50 percent downside. In a new report, ...